Haleon PLC Sponsored ADR $HLN Shares Purchased by Martin Investment Management LLC

Martin Investment Management LLC raised its stake in Haleon PLC Sponsored ADR (NYSE:HLN) by 24.7% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 45,775 shares of the company’s stock after purchasing an additional 9,055 shares during the period. Martin Investment Management LLC’s holdings in Haleon were worth $475,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC boosted its stake in shares of Haleon by 6.1% during the first quarter. Allspring Global Investments Holdings LLC now owns 30,223 shares of the company’s stock worth $306,000 after buying an additional 1,749 shares during the period. Arlington Partners LLC acquired a new position in Haleon in the 2nd quarter valued at about $2,315,000. Acadian Asset Management LLC acquired a new position in Haleon in the 1st quarter valued at about $1,767,000. Concurrent Investment Advisors LLC raised its stake in Haleon by 32.9% during the 1st quarter. Concurrent Investment Advisors LLC now owns 16,363 shares of the company’s stock valued at $168,000 after acquiring an additional 4,055 shares during the last quarter. Finally, Scharf Investments LLC acquired a new stake in Haleon during the 2nd quarter worth approximately $5,096,000. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Analysts Set New Price Targets

HLN has been the topic of several analyst reports. Barclays downgraded Haleon from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, September 16th. Wall Street Zen downgraded Haleon from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. The Goldman Sachs Group raised shares of Haleon from a “neutral” rating to a “buy” rating in a research note on Wednesday, September 10th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Haleon in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $12.33.

Haleon Price Performance

Shares of NYSE:HLN opened at $9.47 on Friday. The stock has a market cap of $42.19 billion, a PE ratio of 24.29, a price-to-earnings-growth ratio of 2.84 and a beta of 0.20. The business’s fifty day moving average price is $9.28 and its two-hundred day moving average price is $9.93. Haleon PLC Sponsored ADR has a one year low of $8.71 and a one year high of $11.42. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.